Curanex Pharmaceuticals earnings were -$1.3M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest CURX earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$954.1k, up 1,481% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CURX reported annual earnings of -$361.5k, with 1,783% growth.
Curanex Pharmaceuticals Earnings Reports & History FAQ
What were Curanex Pharmaceuticals's earnings last quarter?
Curanex Pharmaceuticals (NASDAQ: CURX) reported Q3 2025 earnings per share (EPS) of -$0.04, up 0% year over year. Total CURX earnings for the quarter were -$954.06 thousand. In the same quarter last year, Curanex Pharmaceuticals's earnings per share (EPS) was -$0.04.
Is Curanex Pharmaceuticals profitable or losing money?
As of the last Curanex Pharmaceuticals earnings report, Curanex Pharmaceuticals is currently losing money. Curanex Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$1.29 million, a 464.83% increase year over year.
What was CURX's earnings growth in the past year?
As of Curanex Pharmaceuticals's earnings date in Q4 2025, Curanex Pharmaceuticals's earnings has grown year over year. CURX earnings in the past year totalled -$1.29 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.